Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Sep 26;12(10):1100. doi: 10.3390/vaccines12101100

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Immune correlates of the TMV-HA-con vaccines. BALB/c mice were divided into two experiments: H1-HA and H3-HA groups. All vaccinated groups were intramuscularly (IM) prime/boost immunized with different vaccines at 0- and 21-days post-vaccination (DPV). Following vaccination, five mice from each group were sacrificed at 21 and 35 DPV for collections of blood, spleens, and lungs. Blood was collected and sera were separated and used for hemagglutination inhibition (HI), microneutralization assays, and ELISA. Splenocytes were isolated for use in ELISpot assays. Lungs were homogenized, and lung supernatants were collected and used in HA-specific ELISA.